Charity Atkins

1.7k citations
9 papers · 749 indexed · 1 hit paper · h-index 7
Topics
Growth Hormone and Insulin-like Growth Factors (4 papers)Autophagy in Disease and Therapy (2 papers)Endoplasmic Reticulum Stress and Disease (2 papers)
Partner nations
United StatesNetherlands

In The Last Decade

Charity Atkins

9 papers receiving 732 citations

Hit Papers

Characterization of a Novel PERK Kinase Inhibitor with An...20132026201720212013100200300

Peers

Charity Atkins
Comparison fields: 5 of 74
  • Cell Biology 413
  • Molecular Biology 387
  • Epidemiology 258
  • Surgery 92
  • Oncology 83
Replace Emma L. Davenport with:
Emma L. Davenport United Kingdom
Kattria van der Ploeg United States
Zineb Mounir Canada
Kwang Hong Tay Australia
Ralph A. Highshaw United States
Carolyn Kemp United States
Wenwen Chien United States
Blanca Felipe‐Abrio Spain
Dhruv K. Pant United States
Yuping Chen China
Charity Atkins relative to Emma L. Davenport United Kingdom Emma L. Davenport's profile →
Citations per field
00.5×1.5×2.1×
Emma L. Davenport · 1×
Citations per year

Countries citing papers authored by Charity Atkins

Since Specialization
Citations

This map shows the geographic impact of Charity Atkins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charity Atkins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charity Atkins more than expected).

Fields of papers citing papers by Charity Atkins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charity Atkins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charity Atkins. The network helps show where Charity Atkins may publish in the future.

Co-authorship network of co-authors of Charity Atkins

This figure shows the co-authorship network connecting the top 25 collaborators of Charity Atkins. A scholar is included among the top collaborators of Charity Atkins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charity Atkins. Charity Atkins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1 2
2
Characterization of a Novel PERK Kinase Inhibitor with Antitumor and Antiangiogenic Activitybreakdown →
364
3 170
4 86
5 62
6
Abstract #1740: Characterization of GSK1838705A, a small molecule inhibitor of the insulin-like growth factor-1 receptor and anaplastic lymphoma kinase that delays growth of IGF-1R-dependent tumors and causes regression of ALK-dependent tumors in vivo
2
7 27
8 29
9 7

About Charity Atkins

Charity Atkins is a scholar working on Endocrinology, Diabetes and Metabolism, Neurology and Cell Biology, having authored 9 papers that have together received 749 indexed citations. Recurring topics across this work include Growth Hormone and Insulin-like Growth Factors (4 papers), Autophagy in Disease and Therapy (2 papers) and Endoplasmic Reticulum Stress and Disease (2 papers). The work is most often cited by research in Cell Biology (413 citations), Epidemiology (258 citations) and Molecular Biology (387 citations). Charity Atkins has collaborated with scholars based in United States and Netherlands. Frequent co-authors include Rakesh Kumar, Jeffrey M. Axten, Aaron S. Goetz, Elisabeth A. Minthorn, Thomas B. Stanley, Anthony E. Choudhry, David J. Figueroa, Hasan Alsaid, ShuYun Zhang and Brent Sanders. Their work appears in journals such as Cancer Research, Clinical Cancer Research and Journal of Pharmacology and Experimental Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026